Lani C. Guinier '71, the first tenured woman of color at Harvard Law School, died last Friday at age 71 following a long battle with Alzheimer’s disease. Throughout her law career, she was widely regarded for her trailblazing scholarship in voting rights and racial equity.
Harvard students who test positive for Covid-19 during the spring semester will be required to self-isolate — not move into University-provided isolation housing — and conduct contact tracing themselves, a stark departure from the school’s previous public health policies.
Harvard is not obligated to pay the legal fees of convicted Chemistry professor Charles M. Lieber, Massachusetts’s Supreme Judicial Court ruled Monday.
Harvard will move forward with an in-person spring semester even as Covid-19 cases soar around the United States.
At Harvard, 2021 was a year marked by change. The school’s long-awaited return to in-person operations injected new life into a campus that had been left dormant for over a year by Covid-19. And in an unexpected shift, the University announced its intention to divest its endowment from fossil fuels after a decade of public pressure. Separately, faculty controversies — including a federal conviction and a high-profile departure — ignited debates that rippled across academia. Below, The Crimson looks back at the 10 stories that shaped the last year at Harvard.
Federal officials testified in court Monday that alleged false statements made by Harvard professor Charles M. Lieber prevented government authorities from fully exploring his ties to China.
Harvard professor Charles M. Lieber told the FBI in January 2020 that he “wasn’t completely transparent” in a separate interview with federal investigators two years prior, according to video of an interrogation presented in court by government prosecutors on Friday.
Grappling with its worst on-campus Covid-19 surge since the start of the pandemic, Harvard announced Thursday that it will require affiliates to receive Covid-19 booster shots during the spring semester.
Defense attorneys representing Harvard professor Charles M. Lieber, who is facing trial for allegedly lying to federal investigators about his ties to China, sparred with prosecutors on Thursday over the evidentiary relevance of documents obtained during raids of the prominent chemist’s home and office.
Lawyers for Harvard professor Charles M. Lieber, who is accused of lying to federal investigators about his ties to China, mounted a dramatic defense of the renowned chemist in federal court Wednesday, calling the government’s proof against him “mangled” and “misguided.”
More than 500 Harvard affiliates signed on to an open letter to Visa CEO Alfred F. Kelly, Jr., urging the company to adopt policies they argue will curb the spread of illegal pornographic materials.
As former Harvard Chemistry chair Charles M. Lieber goes on trial on federal charges beginning Tuesday, law and trade experts speculated that his case’s outcome could decide the fate of the Department of Justice’s China Initiative.
Former Harvard Chemistry chair Charles M. Lieber is set to stand trial Tuesday on six federal charges related to his ties to the Chinese government, nearly two years after his initial arrest.
One hundred years since its inception, the case method has evolved into a cornerstone of Harvard Business School.